Viventia Bio (VITA) Acquired

Developing novel antibody drug conjugates for bladder and other cancers.

Health Care -

IPO Performance
Latest Trade ()
First Day Return
Return from IPO
 
Viventia Bio IPO News more
  • .
IPO Data
IPO File Date 10/21/2015
Offer Price
Price Range n/a
Offer Shares (mm) n/a
Deal Size ($mm) $86
 
IPO Data
IPO Date
Offer Price
Price Range n/a
Offer Shares (mm) n/a
Deal Size ($mm) $$86
 
Underwriters
more
Business Overview
Developing novel antibody drug conjugates for bladder and other cancers.
Developing novel antibody drug conjugates for bladder and other cancers.
more
Company Data
Headquarters Winnipeg, , Canada
Founded 1995
Employees 26
Website www.viventia.com
 

Performance vs. IPO Index (IPOUSA)